1 Seminar On Seminar On Synopsis For M.Pharm Dissertation By MULE MADHAV SHESHERAO Under the Guidance of Guide Mr. Kshirsagar R. V. Asst. Professor School of pharmacy SRTMU Nanded Industrial Guide Mr. N. K. Shinde Senior Executive Lupin Research Park School of Pharmacy, SRTMU, Nanded.
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
1
Seminar OnSeminar On
Synopsis For M.Pharm Dissertation
ByMULE MADHAV SHESHERAO
Under the Guidance of
GuideMr. Kshirsagar R. V.
Asst. ProfessorSchool of pharmacy SRTMU Nanded
Industrial GuideMr. N. K. ShindeSenior Executive
Lupin Research Park
School of Pharmacy, SRTMU, Nanded.
2
The period between 1950 to 1970 is considered as period of
Sustained drug release.
The main AIM of preparing sustained release matrix tablet is
intended to modify and improve the drug performance by,
Increasing the duration of drug action and Absorption.
Avoid the fluctuation of plasma drug concentration.
Decreasing the frequency of dosing.
Decreasing the required dose employed.
3
SR matrix tablet describes the slow release over extended
period of time.
The various type of matrices
1. Slow Eroding Matrix
2. Hydrophilic Matrix
3. Plastic Matrix
4
Improved patient compliance: Less frequent dosing
Decreased local and systemic side effects. Decreased GIT irritation. Decreased local inflammation.
Better drug utilisation. Decreased total amount of drug used. Minimum drug accumulation on chronic dosing.
Improved efficiency in treatment. Uniform blood and plasma concentration. Decreased fluctuation in drug level Increased bioavailability of some drugs
5
Dose Dumping: Increase quantity of drug release causes
dumping of drug which in turn leads to toxicity.
Reduced Potential For Accurate Dose Adjustment:
Administrating a fraction of drug is not possible.
Need For Additional Patient Education:
“Do not Crush or Chew the dosage unit”.
“ Tablet residue may appear in stools”.
6
Antidepressant drug is used orally for the treatment of patients with
depression, caused by chemical imbalance on any other reasons. One
of the major problems of this drug is its very poor biological half life
(4hrs), which results in poor bioavailability after oral administration.
Antidepressant drug and its active metabolite inhibit the neuronal
uptake of norepinephrine, serotonin and to a lesser extent dopamine .
Hence it lacks the adverse anticholinergic, sedative and cardiovascular
effects of tricyclic antidepressants. It also requires low dose and it has
less dopamine reuptake activity as compared to other antidepressant
drug.
7
1. To increase the Half life and bioavailability of antidepressant drug.
2. To provide a sustained release formulation of freely water soluble
drugs.
3. To provide a sustained release formulation capable of delivering the
drug substance within 24 hours.
4. To decrease side effect which shown by other antidepressant drug.
8
1. Literature survey.
2. Selection of drug and Initial Studies of Marketed Product
Characterization and Selection of Excipients.
3. Drug excipients compatibility studies.
4. Preparation of trial formulation for in vitro evaluation.
5. Evaluation of trial formulation for every stage of manufacturing viz-
Mixing, blending, compression etc.
6. Evaluation of tablet
7. Stability studies of optimized formulation.
8. Scale-Up and Optimisation Trials towards Commercial Batches.
9. Interpretation of results and Thesis Submission.
9
Margret Chandra et al, (2009): “formulation and evaluation of sustained release
matrix tablets of zidovudine”. By using Kollidon SR, Hydroxypropyl
methylcellulose K15M, K100M as matrix former.
Punit B. Parejiya et al, (2010): “Development and Characterization of Once a
Daily Tablet Formulation of Aceclofenac” Matrix tablets were prepared by direct
compression of Kollidon SR varying proportion with fixed percentage of
aceclofenac.
MD. Selim Reza et al, (2008): “Development of Theophylline Sustained Release
Dosage Form Based on Kollidon SR” Four matrix tablet formulations were
prepared by dry blending and direct compression of Kollidon SR and HPMC-
15cps.
Walid Sakr et al, (2009) Effect of Kollidon SR on the release of Albuterol
Sulphate from matrix tablets evaluate Kollidon SR for the development of extended